Interferon-? ELISPOT as a biomarker of treatment efficacy in latent tuberculosis infection: a clinical trial. (2013)
Attributed to:
Vaccines & Immunity Research MRC Unit, The Gambia
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1164/rccm.201208-1352OC
PubMed Identifier: 23220919
Publication URI: http://europepmc.org/abstract/MED/23220919
Type: Journal Article/Review
Volume: 187
Parent Publication: American journal of respiratory and critical care medicine
Issue: 4
ISSN: 1073-449X